Listed

Standard Biotools Inc.: Form 10-K for the period ended Dec 31, 2018

Filed with the SEC on Mar 18, 2019 and accepted by EDGAR at Mar 18, 2019, 16:12 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2018-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2018-10-01 to 2018-12-31$32.3mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue12 months2018-01-01 to 2018-12-31$113.0mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue12 months2018-01-01 to 2018-12-31$51.3mus-gaap:CostOfGoodsAndServicesSold
Gross profit12 months2018-01-01 to 2018-12-31$61.6mus-gaap:GrossProfit
Research and development12 months2018-01-01 to 2018-12-31$30.0mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative12 months2018-01-01 to 2018-12-31$79.8mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income12 months2018-01-01 to 2018-12-31−$48.2mus-gaap:OperatingIncomeLoss
Interest expense12 months2018-01-01 to 2018-12-31$13.9mus-gaap:InterestExpense
Income tax12 months2018-01-01 to 2018-12-31−$2.4mus-gaap:IncomeTaxExpenseBenefit
Net income12 months2018-01-01 to 2018-12-31−$59.0mus-gaap:NetIncomeLoss
Diluted EPS3 months2018-10-01 to 2018-12-31−$0.36us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS12 months2018-01-01 to 2018-12-31−$1.49us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow12 months2018-01-01 to 2018-12-31−$25.2mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2018-01-01 to 2018-12-31$372.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2018-12-31$95.4mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2018-12-31$127.1mus-gaap:AssetsCurrent
Total assetsAt period end2018-12-31$303.6mus-gaap:Assets
Current liabilitiesAt period end2018-12-31$37.6mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2018-12-31$231.5mus-gaap:Liabilities
Shareholders' equityAt period end2018-12-31$72.1mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001162194-19-000020. Last ingested by Listed: Nov 5, 2026, 21:16 ET. Listed shows no prices and gives no investment advice.